Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: amphotericin b

« Back to Dashboard

Summary for Generic Name: amphotericin b

Tradenames:5
Patents:4
Applicants:9
NDAs:12
Drug Master File Entries: see list15
Suppliers: see list3

Pharmacology for Ingredient: amphotericin b

Clinical Trials for: amphotericin b

To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Status: Completed Condition: Leishmaniasis, Visceral

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
Status: Completed Condition: Visceral Leishmaniasis

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
Status: Active, not recruiting Condition: Invasive Pulmonary Aspergillosis; Lymphoblastic Leukaemia; Myeloblastic Leukaemia; Lymphoblastic Leukemia; Myeloblastic Leukemia

Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Status: Recruiting Condition: Visceral Leishmaniasis

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
Status: Completed Condition: Liver Disease; Fungal Infection

Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Status: Completed Condition: Acute Myelogenous Leukemia; Myelodysplastic Syndrome

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
Status: Terminated Condition: Febrile Neutropenia

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Status: Completed Condition: Visceral Leishmaniasis

Liposomal Amphotericin in Disseminated Leishmaniasis
Status: Completed Condition: Disseminated Leishmaniasis

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
Status: Recruiting Condition: Visceral Leishmaniasis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
AMPHOTERICIN B
amphotericin b
INJECTABLE;INJECTION064141Dec 23, 1996DISCNNo<disabled><disabled>
Abraxis Pharm
AMPHOTERICIN B
amphotericin b
INJECTABLE;INJECTION062728Apr 13, 1987DISCNNo<disabled><disabled>
Apothecon
FUNGIZONE
amphotericin b
INJECTABLE;INJECTION060517Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Apothecon
FUNGIZONE
amphotericin b
LOTION;TOPICAL060570Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Sigma Tau
ABELCET
amphotericin b
INJECTABLE, LIPID COMPLEX;INJECTION050724Nov 20, 1995RXYes6,406,713<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc